Skip to main content

Table 1 Characteristics of patients with and without DM who underwent H. pylori eradication therapy

From: Gastric cancer diagnosed after Helicobacter pylori eradication in diabetes mellitus patients

Total (n = 965)

Non-DM (n = 447)

DM (n = 518)

p

Mean age (range), years

60.7 (27–84)

64.8 (30–86)

<0.0001*

Sex, n (%)

  

<0.0001*

 Female

139 (31.1 %)

97 (18.7 %)

 

 Male

308 (68.9 %)

421 (81.3 %)

 

Mean follow-up period (range), years

4.18 (0.54–13.2)

4.78 (0.68–16.2)

0.0006*

Mean endoscopy interval (range), years

1.37 (0.40–8.38)

1.61 (0.34–8.08)

<0.0001*

Mean body mass index (range), kg/m2

23.1 (14.8–34.9)

23.4 (15.9–32.3)

0.1452

Atrophic gastritis grade, n (%)

  

0.0011*

 Mild

95 (21.3 %)

78 (15.1 %)

 

 Moderate

207 (46.3 %)

215 (41.5 %)

 

 Severe

145 (32.4 %)

225 (43.4 %)

 

Hypertension, n (%)

99 (22.1 %)

244 (47.1 %)

<0.0001*

Hyperlipidemia, n (%)

89 (19.9 %)

220 (42.5 %)

<0.0001*

Hyperuricemia, n (%)

32 (7.16 %)

48 (9.27 %)

0.236

  1. DM diabetes mellitus
  2. *Statistically significant (p < 0.05)